| Original language | English (US) |
|---|---|
| Pages (from-to) | 795-799 |
| Number of pages | 5 |
| Journal | Gastroenterology |
| Volume | 163 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2022 |
Bibliographical note
Funding Information:Conflicts of interest This author discloses the following: Byron P. Vaughn has research support from Takeda, Celgene, Roche, and Diasorin and has received consulting fees from Prometheus. The remaining authors disclose no conflicts.